Periodic Reporting for period 1 - ReDrugBC (Novel therapeutic approaches, based on drug repurposing, for high risk non muscle invasive bladder cancer driven by patients’ proteomic signatures)

The main problem that ReDrugBC is attempting to tackle is the therapeutic challenges at earlier stages of bladder cancer (BC). Despite the recent progress in diagnosis and management, BC remains among the most prevalent cancers worldwide and one of the most costly malignancies...